
Leqembi shows lower progression rate in Alzheimer disease over 3 years, shows new data.
Motivational interviewing can be very useful for addressing patients' ambivalence about psychopharmacologic issues. Take the quiz and learn more.
Which of the following is NOT true of motivational pharmacotherapy?


